Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application
Abstract Immunotherapy, specifically immune checkpoint inhibitors, is revolutionizing cancer treatment, achieving durable control of previously incurable or advanced tumors. However, only a certain group of patients exhibit effective responses to immunotherapy. Anti‐angiogenic therapy aims to block...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley-VCH
2024-01-01
|
| Серія: | Interdisciplinary Medicine |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/INMD.20230025 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|